How to buy Genetic Technologies shares | GTG historical share price and analysis
Finder supports the LGBTIQA+ communities

How to buy Genetic Technologies shares

Own Genetic Technologies shares in just a few minutes.

Updated

Fact checked

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Genetic Technologies Limited is a diagnostics & research business based in Australia. Genetic Technologies shares (GTG) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Genetic Technologies has a trailing 12-month revenue of around $9,864.

How to buy shares in Genetic Technologies

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Genetic Technologies . Find the share by name or ticker symbol: GTG. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Genetic Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Genetic Technologies . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What's in this guide?

  1. Genetic Technologies key stats
  2. Compare share trading platforms
  3. Is Genetic Technologies stock a buy or sell?
  4. Genetic Technologies performance over time
  5. Genetic Technologies 's financials
  6. How volatile are Genetic Technologies shares?
  7. Does Genetic Technologies pay a dividend?
  8. Have Genetic Technologies shares ever split?
  9. Other common questions

Genetic Technologies share price

Use our graph to track the performance of GTG stocks over time.

Genetic Technologies shares at a glance

Information last updated 2021-02-24.
52-week range$0.003 - $0.014
50-day moving average $0.0101
200-day moving average $0.0087
Target price$0.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.002

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
Superhero share trading
AUD 5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Go to site
More Info
Saxo Capital Markets (Classic account)
Finder Award
Saxo Capital Markets (Classic account)
AUD 6.99
No
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading
High quality, low-cost brokerage on global share trading.
Access up to 19,000 global stocks on 36 of the world’s major stock exchanges and enjoy some of the most competitive FX rates on the the market when you trade with Saxo Capital Markets.
Go to site
More Info
CMC Markets Stockbroking
Finder Award
CMC Markets Stockbroking
AUD 11 or 0.1%
No
ASX shares, Global shares, Forex, CFDs, Options trading, mFunds, ETFs, Warrants
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
Go to site
More Info
Bell Direct Share Trading
Finder Award
Bell Direct Share Trading
AUD 15
No
ASX shares, Options trading, mFunds, ETFs, Warrants
Invest in Australian shares, options and managed funds from the one account with no inactivity fee.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
Go to site
More Info
IG Share Trading
Finder Award
IG Share Trading
AUD 8 or 0.1%
AUD 50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares, Forex, CFDs, Margin trading
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Note: $10,000 deposit required to open account.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Go to site
More Info
ANZ Share Investing
ANZ Share Investing
AUD 19.95
No
ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
More Info
Westpac Online Investing Account
Westpac Online Investing Account
AUD 19.95 or 0.11%
USD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, ETFs
More Info
loading

Compare up to 4 providers

Is it a good time to buy Genetic Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Genetic Technologies Limited by TradingView

Genetic Technologies financials

Revenue TTM $9,864
Gross profit TTM $-241,647
Return on assets TTM -48.8%
Return on equity TTM -82.49%
Profit margin 0%
Book value 0.002
Market capitalisation $90.1 million

TTM: trailing 12 months

Genetic Technologies share dividends

We're not expecting Genetic Technologies to pay a dividend over the next 12 months.

Have Genetic Technologies 's shares ever split?

Genetic Technologies 's shares were split on 29 December 1994.

Genetic Technologies share price volatility

Over the last 12 months, Genetic Technologies 's shares have ranged in value from as little as $0.003 up to $0.014. A popular way to gauge a stock's volatility is its "beta".

GTG.AU volatility(beta: 0.85)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Genetic Technologies 's is 0.8463. This would suggest that Genetic Technologies 's shares are less volatile than average (for this exchange).

Genetic Technologies overview

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company engages in the development of various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer name. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site